Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Centene Corp (CNC) vs Paychex, Inc. (PAYX) Price & Performance

Centene CorpTrade
Paychex, Inc.Trade

Price performance (Past 24H)

Key statistics

Centene Corp vs Paychex, Inc. — how do they compare? Centene Corp trades at $65.58 (market cap $32.89B), while Paychex, Inc. trades at $121.14 (market cap $43.10B). The key difference: Paychex, Inc. is the larger of the two by market cap, and Paychex, Inc. pays a 3.93% dividend while Centene Corp pays none. Which is the better fit depends on your goals.

CNCPAYX
Market Cap
$32.89B$43.10B
Sector
HealthIndustrials
52-Week High
$68.72$140.81
52-Week Low
$26.17$85.57
Enterprise Value
$21.93B$46.59B
Dividend Yield
3.93%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Centene Corp

Centene (CNC) trades at $65.77, up 2.48% with a bullish technical signal. Recent Q2 2026 earnings beat expectations with EPS of $2.51 versus $1.09 estimate, driven by margin recovery and cost control. Revenue grew to $194.78B in 2025, though net income was negative at -$6.67B. Valuation ratios are attractive with P/E of 8.06 and P/S of 0.16. Analyst consensus is strongly bullish with 61.37% buy ratings and a $70.36 price target.

Outlook is positive due to raised 2026 guidance and operational improvements, but risks include Medicaid membership softness and persistent negative margins. The stock offers value potential if profitability rebounds as projected, though investors should monitor medical cost trends and regulatory changes affecting government healthcare programs.

Paychex, Inc.

Paychex (PAYX) trades at $120.04, down slightly by 0.07% on the day, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.32 exceeding the $1.31 estimate. Revenue grew to $5.57 billion in 2025, though net income margin dipped to 27.03%. Recent news highlights expansion of its WISE platform and steady small business employment trends, supporting growth prospects.

The outlook remains positive given consistent earnings outperformance and strategic initiatives, but risks include elevated valuation ratios and potential economic sensitivity. Analyst consensus is mixed with a hold-heavy rating, and the current price sits above the $114.50 target, suggesting limited near-term upside. Dividend payments provide income support, yet investors should weigh growth against premium multiples.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC

About Paychex, Inc.

Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.

Read more on PAYX